FIORELLO
DEAD

Serial Number

86492414

Owner

Fiorello Pharmaceuticals, Inc.

Attorney

Karen J Bernstein

Filing Date

Dec 30, 2014

Add to watchlist:

No watchlists yet
View on USPTO

FIORELLO Trademark

Serial Number: 86492414

FIORELLO is a trademark filed by Fiorello Pharmaceuticals, Inc. on December 30, 2014. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Fiorello Pharmaceuticals, Inc.

12 East 49th Street
New York, NY 10017

Entity Type: 03

Trademark Details

Filing Date

December 30, 2014

Registration Date

Not Registered

Published for Opposition

March 8, 2016

Goods & Services

Pharmaceutical preparations and substances for the treatment of pain, neuropathic pain, cancer pain, perioperative pain, cancer symptoms, multiple sclerosis, spasticity, convulsions, seizures, epilepsy, dup 15, Doose syndrome, bladder dysfunction, inflammatory bowel disease, ulcerative colitis, Crohn's disease, Alzheimer's, Dravet syndrome, Lennox-Gastaut syndrome (LGS), spinal cord injury, head injury, bone disorders, chromosome disorders, inflammatory disorders, inflammation, autoimmune disorders, arthritis, metabolic disorders, neurodegenerative diseases, diseases of the central nervous system, peripheral neuropathy, neurogenic symptoms, hypoxic-ischemic encephalopathy, stroke, motion sickness, chemically induced sickness, diabetes, obesity, obesity associated with diabetes, bulimia, anorexia, nausea, loss of appetite, psychiatric disorders, schizophrenia, and drug, alcohol and nicotine abuse; analgesic and muscle relaxation pharmaceutical preparations; herbs for medicinal purposes; medicinal herbs; medicinal oils; medicinal infusions for treating pain, neuropathic pain, cancer pain, perioperative pain, cancer symptoms, multiple sclerosis, spasticity, convulsions, seizures, epilepsy, dup 15, Doose syndrome, bladder dysfunction, inflammatory bowel disease, ulcerative colitis, Crohn's disease, Alzheimer's, Dravet syndrome, Lennox-Gastaut syndrome (LGS), spinal cord injury, head injury, bone disorders, chromosome disorders, inflammatory disorders, inflammation, autoimmune disorders, arthritis, metabolic disorders, neurodegenerative diseases, diseases of the central nervous system, peripheral neuropathy, neurogenic symptoms, hypoxic-ischemic encephalopathy, stroke, motion sickness, chemically induced sickness, diabetes, obesity, obesity associated with diabetes, bulimia, anorexia, nausea, loss of appetite, psychiatric disorders, schizophrenia, and drug, alcohol and nicotine abuse; medical infusions for muscle relaxation for treating back pain, muscle spasms, spinal and joint strains; extracts of medicinal plants and herbs for medical, veterinary and pharmaceutical purposes; foodstuffs for medicinal purposes, namely, medicated supplements for foodstuffs for babies and animals; food supplements for humans and animals; herbal supplements; herb teas for medicinal purposes

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Jun 3, 2019 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Jun 3, 2019 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 10, 2019 EXRA
SOU EXTENSION 5 GRANTED
Apr 9, 2019 EX5G
SOU EXTENSION 5 FILED
Nov 2, 2018 EXT5
SOU TEAS EXTENSION RECEIVED
Nov 2, 2018 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 5, 2018 EXRA
SOU EXTENSION 4 GRANTED
May 3, 2018 EX4G
SOU EXTENSION 4 FILED
May 3, 2018 EXT4
SOU TEAS EXTENSION RECEIVED
May 3, 2018 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 27, 2018 EXRA
SOU EXTENSION 3 GRANTED
Jan 26, 2018 EX3G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jan 26, 2018 AITU
ASSIGNED TO EXAMINER
Jan 9, 2018 DOCK
NOTICE OF REVIVAL - E-MAILED
Jan 2, 2018 NREV
SOU EXTENSION RECEIVED WITH TEAS PETITION
Jan 2, 2018 TPEX
PETITION TO REVIVE-GRANTED
Jan 2, 2018 PETG
TEAS PETITION TO REVIVE RECEIVED
Jan 2, 2018 PROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 28, 2017 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 28, 2017 REAP
ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Dec 4, 2017 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Dec 4, 2017 ABN6
SOU EXTENSION 3 FILED
Nov 3, 2017 EXT3
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 5, 2017 EXRA
SOU EXTENSION 2 GRANTED
May 3, 2017 EX2G
SOU EXTENSION 2 FILED
May 3, 2017 EXT2
SOU TEAS EXTENSION RECEIVED
May 3, 2017 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 5, 2016 EXRA
SOU EXTENSION 1 GRANTED
Nov 3, 2016 EX1G
SOU EXTENSION 1 FILED
Nov 3, 2016 EXT1
SOU TEAS EXTENSION RECEIVED
Nov 3, 2016 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 3, 2016 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 8, 2016 NPUB
PUBLISHED FOR OPPOSITION
Mar 8, 2016 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 17, 2016 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Feb 1, 2016 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 26, 2016 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 25, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 25, 2016 CRFA
ASSIGNED TO LIE
Jan 20, 2016 ALIE
NOTICE OF REVIVAL - E-MAILED
Jan 7, 2016 NREV
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 6, 2016 TROA
PETITION TO REVIVE-GRANTED
Jan 6, 2016 PETG
TEAS PETITION TO REVIVE RECEIVED
Jan 6, 2016 PROA
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Nov 6, 2015 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Nov 6, 2015 ABN2
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 21, 2015 TCCA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 10, 2015 GNRN
NON-FINAL ACTION E-MAILED
Apr 10, 2015 GNRT
NON-FINAL ACTION WRITTEN
Apr 10, 2015 CNRT
ASSIGNED TO EXAMINER
Apr 7, 2015 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 12, 2015 NWOS
NEW APPLICATION ENTERED
Jan 2, 2015 NWAP